Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2015

Open Access 01-12-2015 | Research article

Using films as a psychoeducation tool for patients with schizophrenia: a pilot study using a quasi-experimental pre-post design

Authors: Christian von Maffei, Frauke Görges, Werner Kissling, Wolfgang Schreiber, Christine Rummel-Kluge

Published in: BMC Psychiatry | Issue 1/2015

Login to get access

Abstract

Background

Relapses and, subsequently, readmissions are common in patients with schizophrenia. Psychoeducation has been shown to reduce the number and duration of readmissions. Yet, only little more than 20% of psychiatric patients in German speaking countries receive psychoeducation. Among other reasons, costs may be considered too high by hospitals. The objective of the present study was to test the feasibility of a new cost-efficient approach in the psychoeducation of patients with schizophrenia. In this study, films were used to impart knowledge about the illness to inpatients.

Methods

A total of 113 participants were initially included in the study, eleven of which were not included in the final analyses. Six films about the symptoms, diagnosis, causes, warning signs, treatment of schizophrenia and about the influence of family members and friends were shown in a group setting in the presence of nursing staff. All films combined facts, expert opinions, and personal experiences of peers. As the main outcome criterion of this feasibility pilot study, we measured the effects on knowledge. Secondary outcome measures included compliance, insight into illness, side effects, and quality of life. Data were collected directly after the intervention and about half a year afterwards. The number and the duration of readmissions to the hospital were recorded and compared to the number and duration of prior admissions. Patients were also asked to state their subjective opinion about the films. Main data analyses were done using paired t-tests and Wilcoxon signed-rank tests. Secondary analyses also involved ANOVAs and ANCOVAs.

Results

One hundred and two inpatients were included in the data analyses. Showing the films in the tested setting was shown to be feasible. Knowledge about schizophrenia (p < .001), compliance (ps < .01), insight into illness (p < .01), and quality of life (p < .001) all increased significantly after patients had watched the films and remained stable for at least half a year. A vast majority (84.9%) of the patients found the films to be interesting and informative.

Conclusions

Using films to educate inpatients about schizophrenia is a feasible method that is cost- and time-efficient and well received by the patients.
Literature
1.
Schooler NR. Relapse and rehospitalization: comparing oral and depot antipsychotics. J Clin Psychiatry. 2003;64 Suppl 16:14–7.PubMed
2.
Kissling W, Leucht S. Results of treatment of schizophrenia: is the glass half full or half empty? Int Clin Psychopharmacol. 1999;14 Suppl 3:S11–4.CrossRefPubMed
3.
Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63:892–909.CrossRefPubMed
4.
Jeffreys SE, Harvey CA, McNaught AS, Quayle AS, King MB, Bird AS. The Hampstead Schizophrenia Survey 1991. I: Prevalence and service use comparisons in an inner London health authority, 1986–1991. Br J Psychiatry. 1997;170:301–6.CrossRefPubMed
5.
Weiden P, Glazer W. Assessment and treatment selection for "revolving door" inpatients with schizophrenia. Psychiatr Q. 1997;68:377–92.CrossRefPubMed
6.
Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161:692–9.CrossRefPubMed
7.
Rummel-Kluge C, Schuster T, Peters S, Kissling W. Partial compliance with antipsychotic medication is common in patients with schizophrenia. Aust N Z J Psychiatry. 2008;42:382–8.CrossRefPubMed
8.
Gibson S, Brand SL, Burt S, Boden ZVR, Benson O. Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why. BMC Psychiatry. 2013;13:153.CrossRefPubMedPubMedCentral
9.
Rettenbacher MA, Hofer A, Eder U, Hummer M, Kemmler G, Weiss EM, et al. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication. J Clin Psychiatry. 2004;65:1211–8.CrossRefPubMed
10.
Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997;23:637–51.CrossRefPubMed
11.
Anselmetti S, Bechi M, Bosia M, Quarticelli C, Ermoli E, Smeraldi E, et al. ‘Theory’of mind impairment in patients affected by schizophrenia and in their parents. Schizophr Res. 2009;115:278–85.CrossRefPubMed
12.
Nuechterlein KH, Ventura J, Subotnik KL, Bartzokis G. The early longitudinal course of cognitive deficits in schizophrenia. J Clin Psychiatry. 2014;75:25.CrossRefPubMedPubMedCentral
13.
Thieda P, Beard S, Richter A, Kane J. An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatr Serv. 2003;54:508–16.CrossRefPubMed
14.
15.
Nose M, Barbui C, Gray R, Tansella M. Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry. 2003;183:197–206.CrossRefPubMed
16.
Bauml J, Frobose T, Kraemer S, Rentrop M, Pitschel-Walz G. Psychoeducation: a basic psychotherapeutic intervention for patients with schizophrenia and their families. Schizophr Bull. 2006;32 Suppl 1:S1–9.CrossRefPubMedPubMedCentral
17.
Rummel-Kluge C, Pitschel-Walz G, Kissling W. A fast, implementable psychoeducation program for schizophrenia. Psychiatr Serv. 2007;58:1226.CrossRefPubMed
18.
Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2011;15(6):CD002831.
19.
Pitschel-Walz G. Die Einbeziehung der Angehörigen in die Behandlung schizophrener Patienten und ihr Einfluss auf den Krankheitsverlauf. In: Lang P, editor. [Europäische Hochschulschriften. Reihe VI, Psychologie Publications universitaires européennes. Série VI, Psychologie European university studies. Series VI, Psychology, vol. 581], vol. 19. Frankfurt am Main, New York; 1997. p. 99–118.
20.
Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2011.15;(6):CD002831.
21.
Pitschel-Walz G, Bauml J, Bender W, Engel RR, Wagner M, Kissling W. Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich psychosis information project study. J Clin Psychiatry. 2006;67:443–52.CrossRefPubMed
22.
Pitschel Walz G, Boerner R, Mayer CER, Peuker I, Welschehold M, Bender W, et al. Informationszentrierte gruppen für schizophrene patienten und deren angehörige: einfluß von wissen, krankheitskonzept und expressed emotions (PIP-studie). In: Bender W, Hubmann W, Mohr F, editors. Neuere entwicklungen in der behandlung schizophrener psychosen. München-Haar: VTS-Verlag; 1995.
23.
Rummel-Kluge C, Pitschel-Walz G, Bauml J, Kissling W. Psychoeducation in schizophrenia–results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland. Schizophr Bull. 2006;32:765–75.CrossRefPubMedPubMedCentral
24.
Rummel-Kluge C, Kluge M, Kissling W. Frequency and relevance of psychoeducation in psychiatric diagnoses: results of two surveys five years apart in German-speaking European countries. BMC Psychiatry. 2013;13:170.CrossRefPubMedPubMedCentral
25.
Rummel-Kluge C, Stiegler-Kotzor M, Schwarz C, Hansen W, Kissling W. Peer-counseling in schizophrenia: patients consult patients. Patient Educ Couns. 2008;70:357–62.CrossRefPubMed
26.
McGill CW, Patterson CJ. Former patients as peer counselors on locked psychiatric inpatient units. Psychiatr Serv. 1990;41:1017–9.CrossRef
27.
Rummel CB, Hansen W, Helbig A, Pitschel-Walz G, Kissling W. Peer-to-peer psychoeducation in schizophrenia: a new approach. J Clin Psychiatry. 2005;66:1580–5.CrossRefPubMed
28.
Bäuml J, Pitschel-Walz G. Psychoedukation bei schizophrenen Erkrankungen: Konsensuspapier der Arbeitsgruppe "Psychoedukation bei schizophrenen Erkrankungen". Stuttgart, New York: Schattauer; 2003.
29.
Froböse T, Bäuml J, Jahn T, Pohl C, Pitschel-Walz G. Knowledge gain by psychoeducation for patients with schizophrenia: associations with sociodemographic data, psychopathology, insight and global neurocognitive performance. Int J Clin Psychiatry Mental Health. 2014;2:111–21.CrossRef
30.
Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res. 2000;42:241–7.CrossRefPubMed
31.
Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry. 1993;1:873.
32.
Hays WL. Statistics for the social sciences. 2nd ed. New York: Holt, Rinehart and Winston; 1973.
33.
Markowitz M, Karve S, Panish J, Candrilli SD, Alphs L. Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization. BMC Psychiatry. 2013;13:246.CrossRefPubMedPubMedCentral
34.
McFarlane WR, Dixon L, Lukens E, Lucksted A. Family psychoeducation and schizophrenia: a review of the literature. J Marital Fam Ther. 2003;29:223–45.CrossRefPubMed
35.
Cohen AN, Glynn SM, Murray-Swank AB, Barrio C, Fischer EP, McCutcheon SJ, et al. The family forum: directions for the implementation of family psychoeducation for severe mental illness. Psychiatr Serv. 2008;59:40–8.CrossRefPubMed
36.
Frank F, Rummel-Kluge C, Berger M, Bitzer EM, Holzel LP. Provision of group psychoeducation for relatives of persons in inpatient depression treatment–a cross-sectional survey of acute care hospitals in Germany. BMC Psychiatry. 2014;14:143.CrossRefPubMedPubMedCentral
37.
Farrelly S, Clement S, Gabbidon J, Jeffery D, Dockery L, Lassman F, et al. Anticipated and experienced discrimination amongst people with schizophrenia, bipolar disorder and major depressive disorder: a cross sectional study. BMC Psychiatry. 2014;14:157.CrossRefPubMedPubMedCentral
38.
Hasson-Ohayon I, Avidan-Msika M, Mashiach-Eizenberg M, Kravetz S, Rozencwaig S, Shalev H, et a. Metacognitive and social cognition approaches to understanding the impact of schizophrenia on social quality of life. Psychiatry Research 2012;200(2-3):802–806.
39.
Hasson-Ohayon I, Ehrlich-Ben Or S, Vahab K, Amiaz R, Weiser M, Roe D. Insight into mental illness and self-stigma: the mediating role of shame proneness. Psychiatry Res. 2012;200:802–6.CrossRefPubMed
40.
Hasson-Ohayon I, Kravetz S, Roe D, David AS, Weiser M. Insight into psychosis and quality of life. Compr Psychiatry. 2006;47:265–9.CrossRefPubMed
Metadata
Title
Using films as a psychoeducation tool for patients with schizophrenia: a pilot study using a quasi-experimental pre-post design
Authors
Christian von Maffei
Frauke Görges
Werner Kissling
Wolfgang Schreiber
Christine Rummel-Kluge
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2015
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-015-0481-2

Other articles of this Issue 1/2015

BMC Psychiatry 1/2015 Go to the issue

Research article

Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study

Research article

Driving behaviour in adults with attention deficit/hyperactivity disorder

Research article

Depression and anxiety disorder among epileptic people at Amanuel Specialized Mental Hospital, Addis Ababa, Ethiopia

Study protocol

PHEDRE trial protocol – observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population

Study protocol

Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study

Research article

Validation of life-charts documented with the personal life-chart app – a self-monitoring tool for bipolar disorder